Zobrazeno 1 - 10
of 761
pro vyhledávání: '"Gary R Lichtenstein"'
Autor:
David T. Rubin, Walter Reinisch, Thomas Greuter, Paulo G. Kotze, Marcia Pinheiro, Rajiv Mundayat, Eric Maller, Marc Fellmann, Nervin Lawendy, Irene Modesto, Stephan R. Vavricka, Gary R. Lichtenstein
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Introduction: Extraintestinal manifestations (EIMs) in patients with ulcerative colitis (UC) are common. Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of UC. We evaluated the efficacy of tofacitinib in patients with
Externí odkaz:
https://doaj.org/article/e097ca53b86849d19e2e7355909c6a94
Autor:
Gary R. Lichtenstein, Benjamin L. Cohen, Leonardo Salese, Irene Modesto, Wenjin Wang, Gary Chan, Haytham Mohamed Ahmed, Chinyu Su, Laurent Peyrin-Biroulet
Publikováno v:
Digestive Diseases and Sciences. 68:2624-2634
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae82b32df57d3c3d63e043cc22e897f1
https://doi.org/10.1007/s10620-022-07794-0
https://doi.org/10.1007/s10620-022-07794-0
Autor:
Gary R. Lichtenstein, MD, Michael F. Picco, MD, PhD, Sanjeev Solomon, MD, Stephen J. Bickston, MD
Publikováno v:
VideoGIE, Vol 3, Iss 2, Pp 35-42 (2018)
Externí odkaz:
https://doaj.org/article/7cb5beb18cfd49cc9b26a0b3deb7a990
Autor:
Sophie Shubow, Qin Sun, Ai Len Nguyen Phan, Dana C. Hammell, Maureen Kane, Gary H. Lyman, Allan Gibofsky, Gary R. Lichtenstein, Zachary Bloomgarden, Raymond K. Cross, Sarah Yim, James E. Polli, Yow‐Ming Wang
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:37-49
The approval and adoption of biosimilar products are essential to contain increasing healthcare costs and provide more affordable choices for patients. Despite steady progress in the number of the US Food and Drug Administration (FDA) biosimilar appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc4e8a450b0e5f29824c29bffbe05d9
https://doi.org/10.1002/cpt.2765
https://doi.org/10.1002/cpt.2765
Autor:
Shivali Berera, Gary R. Lichtenstein
Publikováno v:
Current Treatment Options in Gastroenterology. 20:81-100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77bcc8bcec4243366cacc149c7b2c0a8
https://doi.org/10.1007/s11938-022-00371-4
https://doi.org/10.1007/s11938-022-00371-4
Publikováno v:
Pediatric Inflammatory Bowel Disease ISBN: 9783031147432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f02eb97b8a28693f21fcd8b3d5db1c33
https://doi.org/10.1007/978-3-031-14744-9_35
https://doi.org/10.1007/978-3-031-14744-9_35
Autor:
Gary R Lichtenstein, Brian Bressler, Carlos Francisconi, Severine Vermeire, Nervin Lawendy, Leonardo Salese, Gosford Sawyerr, Hongjiong Shi, Chinyu Su, Donna T Judd, Thomas Jones, Edward V Loftus
Background In patients with ulcerative colitis (UC), risks of infection and malignancies increase with age. Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of UC. This analysis assessed age as a risk factor for adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94700e81811a66a2373881de060c9ccb
https://lirias.kuleuven.be/handle/20.500.12942/707119
https://lirias.kuleuven.be/handle/20.500.12942/707119
Publikováno v:
Pediatric Inflammatory Bowel Disease ISBN: 9783031147432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1817e9e2aae7696eefe0f2f7ccb222be
https://doi.org/10.1007/978-3-031-14744-9_34
https://doi.org/10.1007/978-3-031-14744-9_34
Autor:
Gary R, Lichtenstein
Publikováno v:
Gastroenterol Hepatol (N Y)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6d0124c27376e68efc311dc2adb9834
https://pubmed.ncbi.nlm.nih.gov/36397818
https://pubmed.ncbi.nlm.nih.gov/36397818
Autor:
Meenakshi Bewtra, Gary R. Lichtenstein, Unmesha Roy Paladhi, Lisa Nessel, Colin Wollack, Jan-Michael A Klaproth, Ali H Harb, Scott G. Daniel, Mark T. Osterman, Akriti Saxena, Ghadeer K. Dawwas, Abhik Roy, Shivali Berera, Vesselin T. Tomov, Erin M. Schnellinger, Shivan J. Mehta, Faten Aberra, Jesse Green, Farzana Rashid, Kyle Bittinger, Anna M. Buchner, Freddy Caldera, Gary D. Wu, Uma Mahadevan, Saha Sumona, James D. Lewis
Publikováno v:
Inflamm Bowel Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b59fb93b9d7000243132b23b04dc7d
https://doi.org/10.1093/ibd/izaa356
https://doi.org/10.1093/ibd/izaa356